Watson-Marlow has announced the ground breaking of its new state-of-the-art manufacturing facility in Devens, Massachusetts, in the US.

A celebration ceremony was held on November 18 at the new facility, which will be dedicated to Watson-Marlow’s range of industry leading products, including peristaltic pumps, tubing, fluid path solutions and BioPure components.

The Devens 14,000 sq.m facility will be close to the life sciences hub in the Cambridge/Boston area, with the site incorporating a suite of eight ISO14644-1 Class 7 cleanrooms, warehousing and offices, with space for two further cleanrooms within the initial footprint.

With segregated cleanroom and non-cleanroom production capabilities, Watson-Marlow’s new facility will strengthen the support the company provides to customers in the region across its core sectors of pharmaceutical and biotechnology, medical diagnostics and process industries, the company said.

“The new US facility is an important milestone in the Watson-Marlow company history and marks a significant commitment to serving our customers in the Americas region,” Andrew Mines, Watson-Marlow Managing Director, said. “This exciting development is bringing us closer to our customers whose purpose is to help the world around us, from advancing cell and gene therapies through to ensuring people have access to clean drinking water. Together we will continue to develop market-leading fluid management solutions to engineer a more sustainable future.”

Production at the new facility will replicate that of Watson-Marlow’s European sites, ensuring continued product quality for customers, by using the same raw materials, components, processes and work instructions. Completion of the facility is due in late 2022, with the first products due to be shipped from the site late in the December quarter.